Format

Send to

Choose Destination
Eur Heart J Cardiovasc Imaging. 2017 May 1;18(5):489-498. doi: 10.1093/ehjci/jew309.

Appropriateness criteria for the use of cardiovascular imaging in heart valve disease in adults: a European Association of Cardiovascular Imaging report of literature review and current practice.

Author information

1
Cardiothoracic Centre, Guy's and St Thomas Hospitals, London, UK.
2
King's Health Partners, King's College Hospital NHS Foundation Trust, London, UK.
3
Departments of Cardiology and Radiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
4
John Radcliffe Hospital, Oxford, UK.
5
University Hospital Sart Tilman, Liège, Belgium.
6
Aix-Marseille University, URMITE, Marseille, France.
7
Department of Cardiology, APHM, La Timone Hospital, Marseille, France.
8
University Alcala, Ramon y Cajal Hospital, Madrid, Spain.
9
Department of Cardiology and Centre of Cardiological Innovation, Oslo University Hospital, Rikshospitalet and University of Oslo, Oslo, Norway.
10
Department of Cardiology, University of Liège Hospital, GIGA Cardiovascular Sciences, Heart Valve Clinic, CHU Sart Tilman, Liège, Belgium.
11
Gruppo Villa Maria Care and Research, Anthea Hospital, Bari, Italy.

Abstract

Heart valve disease is common and a major indication for imaging. Echocardiography is the first-line imaging technique for diagnosis, assessment, and serial surveillance. However, other modalities, notably cardiac magnetic resonance imaging and computerized tomography, are used if echocardiographic imaging is suboptimal or to obtain complementary information, particularly to aid risk assessment in individual patients. This review is a summary of current evidence for state-of-the-art clinical practice to inform appropriateness criteria for heart valve disease. It is divided according to common clinical scenarios: detection of valve disease, assessment of the valve and other cardiac structures, risk assessment, screening, and intervention.

KEYWORDS:

heart valve disease; intervention; other cardiac structures assessment; risk assessment; screening; valve assessment; valve disease detection

PMID:
28586420
DOI:
10.1093/ehjci/jew309
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center